1. Australia Stocks

  2. •

    Healthcare

  3. •

    Medical - Distribution
Paragon Care Limited

Paragon Care Limited

PGC.AX
Paragon Care LimitedAU flagAustralian Securities Exchange
0.15
AUD
+0.00
- -
240.02MMarket Cap
Paragon Care Limited
PGC.AX
(Australian Securities Exchange)

Recent

price

0.15

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
FRC
0.09
0.53
0.49
0.46
0.37
0.33
0.46
0.68
0.71
0.67
1.11
0.69
0.7
0.55
0.47
3.18
Revenue per Share
-0.03
0.01
0.03
- -
0.02
0.02
0.03
0.06
0.06
0.05
-0.06
-0.23
0.02
0.01
0.02
0.01
Basic EPS, GAAP
-0.04
- -
-0.01
-0.02
0.01
-0.04
-0.01
0.04
0.04
-0.03
-0.04
-0.02
-0.02
-0.01
-0.03
-0.02
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
0.01
0.01
0.01
0.02
0.02
0.05
- -
- -
- -
0.01
0.01
Dividend per Share
0.21
0.18
0.15
0.19
0.22
0.31
0.29
0.53
0.5
0.84
0.6
0.34
0.34
0.5
0.35
0.31
Book Value per Share
0.22
-0.45
-0.32
-0.06
0.04
0.08
0.02
-0.06
-0.09
-0.1
-0.04
-0.11
-0.09
- -
-0.01
-0.41
Tangible Book Value per Share
13
16
30
34
46
59
70
137
166
203
320
338
338
454
655
935
Basic Weighted Avg Shares
1
8
15
16
17
19
32
93
117
137
355
232
236
248
308
2,970
Sales/Revenue/Turnover
-33.6
-11.35
-3.86
-0.93
5.52
6.18
9.34
11.24
12.36
6.29
7.48
0.89
7.4
7.55
7.83
0.96
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
1
1
2
10
8
6
8
10
14
Depreciation Expense
- -
- -
1
- -
1
1
2
8
10
11
-19
-77
8
7
11
8
Net Income, GAAP
- -
- -
- -
- -
- -
2.65
22.01
23.7
28.52
19.89
47.65
- -
32.86
33.16
24.93
40.36
Effective Tax Rate (%)
-32.34
1.78
5.81
-0.49
4.33
5.61
6.53
8.07
8.69
8.02
-5.22
-33.35
3.51
2.68
3.5
0.28
Profit Margin (%)
2
- -
-5
1
3
7
6
27
15
67
65
21
31
71
39
186
Working Capital
- -
4
3
4
3
3
7
31
29
94
108
95
88
105
100
135
LT Debt
3
3
5
6
10
18
21
73
83
170
192
112
122
242
252
292
Total Equity
- -
- -
- -
- -
- -
6.23
8.37
11.05
8.93
3.47
4.72
- -
5.07
4.11
4.8
3.33
Return on Invested Capital (%)
- -
- -
- -
- -
- -
8.02
9.59
12.07
9.91
6.44
-4.69
- -
5.74
3.35
3.4
3.61
Return on Capital (%)
-22.83
5.5
23.18
-1.4
8.84
7.6
10.89
16.13
13.05
8.65
-10.26
-50.64
7.27
3.87
4.67
3.2
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
48.48%
17.15%
15.74%
Free Cash Flow
-117.54%
53.56%
-10.17%
Net Income, GAAP
35.16%
45.25%
-22.11%
Sales/Revenue/Turnover
132.02%
172.32%
865.41%
Total Cash Common Dividend
- -
- -
59.94%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
248
2023
- -
- -
- -
- -
308
2024
- -
- -
- -
- -
2,970

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
0.01
2023
- -
- -
- -
- -
0.02
2024
- -
- -
- -
- -
0.01

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
0.01
2024
- -
- -
- -
- -
0.01
Similar Companies
Suzuken Co., Ltd. (SZUKF)
Oriola Oyj (0NES.L)
Hanmi Science Co., Ltd. (008930.KS)
MediPal Holdings Corporation (MAHLY)
MedFirst Healthcare Services, Inc. (4175.TWO)
Arjo AB (publ) (ARRJF)
Business
Paragon Care Limited (ASX:PGC) is an Australia-based healthcare company that supplies medical equipment, devices, consumables, and related services to acute care, aged care, veterinary, and ancillary healthcare markets across Australia, New Zealand, and Asia. The company operates through four specialty pillars, including Capital & Consumables encompassing durable medical equipment, pharmaceuticals, nutritional products, over-the-counter items, and medical supplies; Specialty Diagnostics featuring reagent red blood cells, monoclonal blood grouping reagents, ancillary immunohematology products, and laboratory equipment; Specialty Devices covering eye care solutions for optometry and ophthalmic surgery, orthopaedic prosthetics for hips and knees, pain management systems, robotics, dental services, and aesthetics products; and Service & Technology providing equipment maintenance, repairs, preventative programs, technical support, and lifecycle management via a network of over 50 engineers. Founded in 1994 and headquartered in South Melbourne, Victoria, Paragon Care serves healthcare providers, hospitals, laboratories, aged care facilities, and veterinary practices with a focus on advanced technology solutions driven by ageing populations and rising healthcare demands. In June 2024, Paragon Care completed a major merger with CH2 Holdings Pty Limited (also known as Clifford Hallam), integrating distribution of pharmaceuticals, medical consumables, and nutritional products to create a leading healthcare wholesaler and distributor with enhanced scale across Australia, New Zealand, and Asia. The company reported underlying revenue exceeding A$3.6 billion and EBITDA of A$95.2 million for the fiscal year ended June 30, 2025, with 20% revenue growth in Asia to A$101 million, alongside launches of new divisions in aesthetics, robotics, and dental services. In November 2025, Paragon Care agreed to acquire Haju Medical, an Indonesian aesthetics services provider, for A$70 million to expand its Asia-Pacific footprint, with completion expected by January 2026 subject to regulatory approvals; this follows strategic expansions supported by new working capital facilities in New Zealand and Thailand.

Company News

APIChatGPT

  • defenseworld.net

    David Collins Buys 2,000,000 Shares of Paragon Care (ASX:PGC) Stock